Start your free assessment to get prescribed →
IV Drip BarHow it worksBlood TestingPepti OnePepti PenCreator PartnershipsAccountGet started →
All articlesNews

Compounded Peptides in 2026: What’s Legal & What’s Changing?

August 18, 2026 · By the Pepti team

The Regulatory Status of Compounded Peptides in 2026

As 2026 unfolds, the landscape for compounded peptide therapies—including popular options like Melanotan II—continues to evolve. The FDA’s approach to peptides, ongoing legal updates, and shifting state regulations all impact patient access and prescriber protocols. Whether you’re seeking skin pigmentation support, accelerated recovery, or weight management, understanding the current rules is key to safe and effective therapy.

What Are Compounded Peptides?

Compounded peptides are formulations created by specialized pharmacies—custom-made for individual patients based on a doctor’s prescription. Unlike FDA-approved drugs, these medications are generally prepared in 503A compounding pharmacies under the oversight of state boards of pharmacy and the FDA.

Popular compounded peptides prescribed by [pepti] include:

What Changed in Recent Years?

The FDA has increased its scrutiny of compounded peptides since the early 2020s. Some peptides—especially those on the "bulks list"—faced restrictions for compounding, while others remained available if a clinical need was documented and no FDA-approved alternative existed.

Key milestones:

  • 2023–2024: The FDA clarified bulk substance rules, restricting compounding of certain peptides. However, some remained accessible by prescription.
  • 2025: Several state pharmacy boards adopted stricter protocols for patient justification and pharmacy compliance.
  • 2026: Melanotan II and other peptides compounded for physician-supervised use remain available in select telehealth and in-person clinics when prescribed for a specific individual.

Is Melanotan II Still Available?

Yes—under current 2026 regulations, Melanotan II can still be prescribed when a clinician determines it’s appropriate for the patient, and the compounding pharmacy adheres to all federal and state requirements. It is not FDA-approved for any use and can only be accessed via a valid doctor’s prescription, with the product tailored to the individual rather than mass-marketed.

Quick facts:

  • Only licensed 503A compounding pharmacies may dispense Melanotan II for individual patients.
  • Online sales without a prescription remain illegal.
  • Safety and efficacy are continually reviewed, so the legal landscape may evolve.

Why Blood Testing Matters for Peptide Therapy

Regulations now emphasize safety. Before starting or renewing compounded peptides (like Semaglutide or CJC-1295 / Ipamorelin), many clinics—[pepti] included—require baseline bloodwork and periodic follow-ups. This ensures:

  • Safe therapy: Detect unseen risks or contraindications.
  • Effective dosing: Track progress and adjust as needed.
  • Compliance: Meet evolving pharmacy and medical board regulations.

Pepti offers blood testing via convenient at-home kits and in-clinic draws. Explore the biomarkers we test for a detailed look at what’s measured.

What Patients Should Know in 2026

  • Access remains: Compounded peptides (including Melanotan II) are still available with a prescription from licensed providers.
  • Usage guidelines: Strict documentation and doctor supervision are required. Self-sourcing or non-prescription use is illegal and risky.
  • Quality matters: Choose clinics using accredited compounding pharmacies and science-backed protocols.
  • Monitoring is key: Baseline and regular bloodwork help maximize safety and results.

Products to Watch in 2026

Some of the most widely prescribed compounded peptides at pepti this year include:

All are subject to current compounding rules, so check with your provider for updates on availability and required monitoring.


Frequently asked questions

Is compounded Melanotan II legal in 2026?

Yes, when prescribed by a licensed provider and dispensed by a regulated compounding pharmacy for an individual patient, compounded Melanotan II remains accessible under current U.S. law. However, non-prescription or bulk sales remain illegal, and the regulatory environment is subject to change.

Why do I need bloodwork before starting peptide therapy?

Bloodwork helps ensure your therapy is safe, personalized, and effective. It allows providers to detect any potential risks, optimize your dosing, and meet regulatory requirements. Pepti’s blood testing makes this process simple, offering both at-home and in-lab options.

Will compounded peptide access change again soon?

Peptide regulations are dynamic. The FDA and state boards review safety data continually, and new rules could impact access in the future. It’s important to stay informed and work with providers who prioritize compliance and patient safety.


Curious which compounded peptides are right for you? Take your free assessment at pepti and get started today!

— Get started

Ready to start?

Free 5-minute assessment. Physician review within 24 hours. Medication on your doorstep within a week.

Start free assessment

More to read

The assessment process available on the [pepti] website asks a series of medical questions, and the answers provided are reviewed by an independent licensed physician affiliated with our partner physician network. The licensed providers have established exclusionary criteria, and the answers provided determine if the individual is screened out of eligibility for treatment. The licensed clinicians retain the sole decision to prescribe peptide therapy and other compounded medications to patients. Treatment may be denied at the physician's sole discretion. If a prescription is not approved, you will not be charged for the medication.

Pharmacy Providers. [pepti] is a technology platform and is not a healthcare provider, pharmacy, or prescriber. All medications offered through the platform are compounded by independent FDA-registered 503A or 503B compounding pharmacies based on a valid prescription written by a licensed physician for an individual patient. Compounded medications are not FDA-approved as products. The active pharmaceutical ingredients used by our partner pharmacies are sourced from FDA-registered facilities. Compounded medications may not undergo the same testing or quality control as commercially manufactured FDA-approved drugs.

Results vary. Results from peptide therapy and other compounded treatments vary based on individual factors, including age, weight, medical history, adherence to the prescribed protocol, lifestyle factors, and physiological response. [pepti] makes no guarantee of any specific outcome. Statements about peptide therapy and compounded medications offered through the platform have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Product images. Product photographs and renderings shown on this website are for illustrative purposes only. The appearance of vials, packaging, labeling, and other materials you receive may vary and is determined by the dispensing compounding pharmacy.

Off-label use.Many peptides offered through the platform are prescribed for off-label use. “Off-label” means the medication is being prescribed for a use, dose, or patient population that is not specifically approved by the FDA. Off-label prescribing is legal and common in U.S. medical practice when supported by clinical experience and judgment.

Mailing & shipping. Pepti currently dispenses prescription medication to patients in all 50 states and Washington, D.C.. All orders ship in unbranded, tamper-evident packaging via expedited delivery from our partner compounding pharmacies. Temperature-sensitive medications ship with insulated packaging and ice packs. Shipping is included at no additional cost. We do not currently ship medication outside all 50 states and Washington, D.C., internationally, or to APO/FPO addresses.

Not for emergencies. [pepti] is not designed for medical emergencies. If you are experiencing a medical emergency, call 911 or go to your nearest emergency room immediately. For urgent but non-emergency medical questions, contact your primary care provider or use an urgent care service.

No doctor-patient relationship with [pepti]. Your use of the platform does not create a doctor-patient relationship between you and pepti LLC. A doctor-patient relationship is established only between you and the independent licensed physician who reviews your intake and prescribes your treatment. The physicians who use the platform are independent contractors and are solely responsible for the medical care they provide.

Prescription medications. All prescription products require a valid prescription from a licensed healthcare provider. By using the platform, you acknowledge that you are at least 18 years old and that the information you provide is true, accurate, current, and complete. Providing false information may result in inappropriate treatment recommendations or denial of service.

Cosmetic & wellness products.Certain products offered through [pepti] — including skincare, hair care, body care, supplements, men's grooming, sports recovery, and sexual wellness products — are cosmetic or dietary supplement products, not prescription medications. These products do not require a prescription and are not reviewed or prescribed by a physician. Statements regarding dietary supplements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Results vary by individual. Consult your healthcare provider before starting any new supplement or topical product, especially if you are pregnant, nursing, or taking other medications.

pepti LLC · Delaware Limited Liability Company · 131 Continental Dr, Suite 305, Newark, DE 19713 · For media or partnership inquiries, email hello@hellopepti.com. For patient support, email support@hellopepti.com. For privacy and HIPAA inquiries, email privacy@hellopepti.com.